Diabetes Education News

Women who quit smoking and were treated with the GLP-1 receptor agonist dulaglutide were less likely to experience substantial weight gain compared with those who received placebo, according to researchers.

Disordered eating behaviors were reported by 42.5% of adolescents with type 1 diabetes who currently use or previously used an insulin pump, according to findings published in Diabetes Technology & Therapeutics.

The development of incretin-based molecules has led to therapies that can induce greater reductions in HbA1c and body weight for people with type 2 diabetes and obesity than other classes of medication, according to a speaker

Almost 40% of patients with type 2 diabetes stopped taking their second-line medication within 1 year, putting them at risk for future hospitalization related to diabetes, according to researchers.

Composite CVD risk factor control for U.S. adults with type 2 diabetes remains poor, but clinicians can use newer risk scores to better assess patients and prevent CV events with targeted therapies, according to a speaker.

Medications that target bile acid-triggered pathways and combination therapies could be the key for treating nonalcoholic steatohepatitis for young people with obesity and type 2 diabetes, according to a speaker.

Compared with men, women with prediabetes may benefit from earlier intervention to prevent cardiovascular disease, according to a presenter at the World Congress Insulin Resistance Diabetes & Cardiovascular Disease Conference.

New guidance on obesity management and cardiovascular disease screening for people with diabetes are among the updates in the American Diabetes Association’s 2024 Standards of Care.

A Janus kinase inhibitor may preserve beta-cell function for children and young adults recently diagnosed with type 1 diabetes, according to findings published in The New England Journal of Medicine.

Adults with type 2 diabetes who used an artificial intelligence-based app to manage their basal insulin reached their optimal dose in a shorter amount of time than adults receiving standard of care, according to a study data.